1. Home
  2. BDTX

BDTX

Black Diamond Therapeutics Inc.

Logo Black Diamond Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-17-2024 10:32am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Founded: 2014 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 271.0M IPO Year: 2020
Target Price: $12.25 AVG Volume (30 days): 605.6K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.88 EPS Growth: N/A
52 Week Low/High: $1.43 - $6.85 Next Earning Date: 05-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: